Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY4268989 (MORF-057) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
- Status
- RECRUITING
- Phase
- PHASE1
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Status
- RECRUITING
- Phase
- PHASE3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1